Outcome of the meeting to be held today i.e., Friday, 25th September, 2026 for conversion of warrants.

HEMO ORGANIC LIMITED CIN - L24231GJ1992PLC018224 Address: Shop 1 to 3, First floor, Piyu Apartment Opp Electricity Sub Station & Mahesh Nagar, Nr. Radhika Chambers & Jay Amarnath Society, Nikol Gam Road, Uttamnagar, Ahmedabad, Gujarat, India – 382 350 Email ID: hemoorganic@gmail.com Website: www.hemoorganic.co Ph. No. 8238557874 Date: 25th September, 2026 BSE Limited Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai – 400001. Dear Sir/Ma’am, Sub: Outcome of Board Meeting held today i.e., Friday, 25th September, 2026 and Intimation under regulation 30 of SEBI (LODR) Regulation, 2015 Ref: Scrip Code: 524590 | Symbol: HEMORGANIC | ISIN: INE422G010155 In continuation of the Board Meetings held on 26th February, 2026, 17th September, 2026 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, at its meeting held today, i.e., Friday, 25th September, 2026, at the registered office of the Company situated at Shop 1 to 3, First floor, Piyu Apartment Opp Electricity Sub Station & Mahesh Nagar, Nr. Radhika Chambers & Jay Amarnath Society, Nikol Gam Road, Uttamnagar, Ahmedabad, Gujarat, India – 382 350, which commenced at 05:00 P.M. and concluded at 05:30 P.M., has considered and approved the allotment of 34,00,000 (Thirty-four Lakh) fully paid-up equity shares pursuant to the conversion of 34,00,000 convertible warrants, having a face value of Rs. 10.00/- (Rupees Ten Only) each, at an issue price of Rs. 12.50/- (Rupees Twelve and Fifty Paise Only) per share (including a premium of Rs. 2.50/- per share), upon receipt of the balance amount, i.e., 75.00% of the issue price per warrant, from the allottees belonging to the Non-Promoter Category, upon exercise of the option to convert the warrants into Equity Shares in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The details of allotment are provided in Annexure – A. The allotment has been made for cash upon receipt of the remaining exercise price of Rs. 9.375/- each (being an amount equivalent to 75.00% of the warrant exercise price of Rs. 12.50/- each), aggregating to Rs. 3,18,75,000/- (Three Crores Eighteen Lakhs Seventy-Five Thousand Only) in one or more tranches i.e. Rs. 2,76,25,000/- and 42,50,000 as per detils mentioned in Annexure A The newly allotted equity shares pursuant to the exercise of warrants on a preferential basis shall rank pari-passu, in all respects with existing equity shares of the Company. Consequent to above allotment, the Paid-Up Equity Share Capital of the Company stands increased as follows: Particulars Number of Equity Amount in Indian Shares Rupees Existing Paid-up Equity Share Capital 34,65,900 3,46,59,000 Post-Allotment Paid-up Equity Share 68,65,900 68,65,9000 Capital The Company shall make an application to the stock exchange for listing and trading of the newly issued and allotted Equity Shares in due course. HEMO ORGANIC LIMITED CIN - L24231GJ1992PLC018224 Address: Shop 1 to 3, First floor, Piyu Apartment Opp Electricity Sub Station & Mahesh Nagar, Nr. Radhika Chambers & Jay Amarnath Society, Nikol Gam Road, Uttamnagar, Ahmedabad, Gujarat, India – 382 350 Email ID: hemoorganic@gmail.com Website: www.hemoorganic.co Ph. No. 8238557874 Further, the requisite information regarding the issuance of securities under Regulation 30 of SEBI (LODR) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 as mentioned in Annexure – B. You are requested to take the same on record. For, Hemo Organic Limited Vishwambar Kameshwar Singh Managing Director DIN: 09822587 HEMO ORGANIC LIMITED CIN - L24231GJ1992PLC018224 Address: Shop 1 to 3, First floor, Piyu Apartment Opp Electricity Sub Station & Mahesh Nagar, Nr. Radhika Chambers & Jay Amarnath Society, Nikol Gam Road, Uttamnagar, Ahmedabad, Gujarat, India – 382 350 Email ID: hemoorganic@gmail.com Website: www.hemoorganic.co Ph. No. 8238557874 ANNEXURE – A (Details of Allotment pursuant to conversion of Convertible Warrants into Equity Shares) Sr. Name of Category No. of Shares 25% of 65% of 10% of No the (Promoter Convertible Allotted Considerati Considerati Considerat . Allottee(s) / Non- Warrants upon on on ion Promoter) Held Conversion Received Received Received under against (Rs.) against Current Allotment Allotment Issue of of Equity Warrants Shares (Rs.) pursuant Conversion Warrants (Rs.) 1. Vacro Non- 17,00,000 17,00,000 53,12,500 1,38,12,500 21,25,000 Enterprises Promoter Private Limited 2. Qmin Non- 17,00,000 17,00,000 53,12,500 1,38,12,500 21,25,000 Realities Promoter Private Limited Total 34,00,000 34,00,000 1,06,25,000 2,76,25,000 42,50,000 HEMO ORGANIC LIMITED CIN - L24231GJ1992PLC018224 Address: Shop 1 to 3, First floor, Piyu Apartment Opp Electricity Sub Station & Mahesh Nagar, Nr. Radhika Chambers & Jay Amarnath Society, Nikol Gam Road, Uttamnagar, Ahmedabad, Gujarat, India – 382 350 Email ID: hemoorganic@gmail.com Website: www.hemoorganic.co Ph. No. 8238557874 ANNEXURE – B Further, the information required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, are as follows: Sr. Particulars Details 1 Type of securities proposed Allotment of fully paid-up equity shares pursuant to conversion to be issued (viz. equity of warrants through preferential basis. shares, convertibles etc.) 2 Type of issuance (further Preferential allotment (on conversion of warrants into equity public offering, rights issue, shares) in accordance with SEBI (Issue of Capital and Disclosure depository receipts (ADR/ Requirements) Regulations, 2018, to allottees belonging to the GDR), qualified institutions “Non-Promoter” category. placement, preferential allotment etc.) 3 Total number of securities Allotment of 34,00,000 fully paid-up Equity Shares pursuant to proposed to be issued or the conversion of 34,00,000 convertible warrants, having a face the total amount for which value of Rs. 10.00/- each at an issue price of Rs. 12.50/- per the securities will be issued share (including a premium of Rs. 2.50/- per share), upon (approximately) receipt of the balance 75.00% of the issue price per warrant, in accordance with SEBI (ICDR) Regulations, 2018. 4. In case of preferential issue the listed entity shall disclose the following additional details to the stock exchange(s): a) N ames of Investors 1. Vacro Enterprises Private Limited 2. Qmin Realities Private Limited b) P ost allotment of securities – outcome of the Name of Pre-Issue No. of Post-Issue subscription Allottee(s) Equity shares Equity Shares Shares allotted after exercise of upon warrants No. of % conversion No. of % shares of shares warrants Vacro 0 0.00 17,00,000 17,00,000 24.76 Enterprises Private Limited Qmin 0 0.00 17,00,000 17,00,000 24.76 Realities Private Limited Convertible Warrants were allotted on February 26, 2026, carrying the right to subscribe to one Equity Share per warrant on receipt of amount at the rate of Rs. 12.50/- per warrant (being 25% of the issue price per warrant.). HEMO ORGANIC LIMITED CIN - L24231GJ1992PLC018224 Address: Shop 1 to 3, First floor, Piyu Apartment Opp Electricity Sub Station & Mahesh Nagar, Nr. Radhika Chambers & Jay Amarnath Society, Nikol Gam Road, Uttamnagar, Ahmedabad, Gujarat, India – 382 350 Email ID: hemoorganic@gmail.com Website: www.hemoorganic.co Ph. No. 8238557874 Pursuant thereto, 34,00,000 Equity Shares have been allotted upon receipt of the balance 75.00% of the issue price per warrant. c) I n case of convertibles - Conversion of 34,00,000 convertible warrants into 34,00,000 intimation on conversion of fully paid-up Equity Shares of face value Rs. 10.00/- each. securities or on lapse of the tenure of the instrument;